We are live on
!
Find out more
CT
Cambridge Trust Portfolio holdings
AUM
$2.64B
Turnover
15.41%
1-Year Est. Return
28.73%
This Fund
S&P 500
This Quarter
Est. Return
+4.79%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.93%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.24%
AUM
$1.61B
AUM Growth
+$43M
(+2.7%)
Cap. Flow
-$20.3M
Cap. Flow
% of AUM
-1.26%
Top 10 Holdings %
Top 10 Hldgs %
26.19%
Holding
254
New
8
Increased
72
Reduced
125
Closed
12
Avg Time Held
3.3
years
Top 10 Avg Time Held
2.2
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$10.3M |
| 2 |
McDonald's
MCD
|
+$9.22M |
| 3 |
Bank of America
BAC
|
+$8.05M |
| 4 |
JPMorgan Chase
JPM
|
+$6.36M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$2.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Europe Financials ETF
EUFN
|
+$21.9M |
| 2 |
SIVB
SVB Financial Group
SIVB
|
+$10.4M |
| 3 |
Estee Lauder
EL
|
+$9.82M |
| 4 |
Starbucks
SBUX
|
+$1.37M |
| 5 |
Amazon
AMZN
|
+$1.36M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.15% |
| 2 | Financials | 18.23% |
| 3 | Healthcare | 12.91% |
| 4 | Consumer Discretionary | 9.74% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
ALPS Medical Breakthroughs ETF
SBIO
$181M
| $766K | 0.05% |
20,552
-1,562
| -7% | -$56.7K |
2017 Q1
5 quarters
|
|
152
iShares MSCI Emerging Markets Small-Cap ETF
EEMS
$374M
| $718K | 0.04% |
15,050
+446
| +3% | +$23.1K |
2017 Q3
3 quarters
|
|
153
Roper Technologies
ROP
$38B
| $707K | 0.04% |
+2,564
| New | +$707K |
2018 Q2
0 quarters
|
|
154
Tennant Co
TNC
$1.13B
| $699K | 0.04% |
8,852
+36
| +0.4% | +$2.69K |
2016 Q1
9 quarters
|
|
155
DELISTED
Coterra Energy
CTRA
| $678K | 0.04% |
28,504
| – | – |
2013 Q2
20 quarters
|
|
156
State Street Technology Select Sector SPDR ETF
XLK
$122B
| $666K | 0.04% |
19,182
-9,076
| -32% | -$311K |
2016 Q4
6 quarters
|
|
157
Amgen
AMGN
$237B
| $656K | 0.04% |
3,556
-163
| -4% | -$28.8K |
2013 Q3
19 quarters
|
|
158
HubSpot
HUBS
$12B
| $656K | 0.04% |
5,234
+646
| +14% | +$76.5K |
2018 Q1
1 quarter
|
|
159
Norwegian Cruise Line
NCLH
$6.81B
| $654K | 0.04% |
13,840
-181
| -1% | -$9.53K |
2016 Q3
7 quarters
|
|
160
T. Rowe Price
TROW
$21.4B
| $653K | 0.04% |
5,623
+343
| +6% | +$39.9K |
2015 Q4
10 quarters
|
|
161
Markel Group
MKL
$22.8B
| $646K | 0.04% |
596
+27
| +5% | +$30.5K |
2017 Q1
5 quarters
|
|
162
iShares National Muni Bond ETF
MUB
$49.2B
| $625K | 0.04% |
5,729
-971
| -14% | -$105K |
2016 Q2
8 quarters
|
|
163
CVS Health
CVS
$117B
| $611K | 0.04% |
9,486
-1,439
| -13% | -$94.8K |
2013 Q2
20 quarters
|
|
164
RingCentral
RNG
$6.23B
| $574K | 0.04% |
8,162
+195
| +2% | +$13.9K |
2018 Q1
1 quarter
|
|
165
Corcept Therapeutics
CORT
$12.5B
| $563K | 0.04% |
35,800
| – | – |
2013 Q2
20 quarters
|
|
166
German American Bancorp
GABC
$1.86B
| $560K | 0.03% |
15,630
+627
| +4% | +$22.3K |
2017 Q2
4 quarters
|
|
167
Deere & Co
DE
$175B
| $557K | 0.03% |
3,986
| – | – |
2013 Q2
20 quarters
|
|
168
Eversource Energy
ES
$25B
| $541K | 0.03% |
9,231
-1,074
| -10% | -$61.8K |
2013 Q2
20 quarters
|
|
169
Moody's
MCO
$81.6B
| $539K | 0.03% |
3,161
-952
| -23% | -$161K |
2016 Q3
7 quarters
|
|
170
VanEck Junior Gold Miners ETF
GDXJ
$7.82B
| $538K | 0.03% |
16,438
-464
| -3% | -$15.3K |
2016 Q1
9 quarters
|
|
171
State Street Health Care Select Sector SPDR ETF
XLV
$46.1B
| $514K | 0.03% |
6,155
-1,401
| -19% | -$116K |
2016 Q4
6 quarters
|
|
172
Philip Morris
PM
$324B
| $510K | 0.03% |
6,312
-352
| -5% | -$29.9K |
2013 Q2
20 quarters
|
|
173
iShares Russell 1000 Growth ETF
IWF
$125B
| $504K | 0.03% |
14,032
-6,232
| -31% | -$220K |
2015 Q2
12 quarters
|
|
174
Nike
NKE
$54.8B
| $495K | 0.03% |
6,210
-115
| -2% | -$8.1K |
2013 Q2
20 quarters
|
|
|
INXN
175
DELISTED
Interxion Holding N.V.
INXN
| $466K | 0.03% |
7,464
+100
| +1% | +$6.39K |
2018 Q1
1 quarter
|
|
Similar funds
ZCM
CQS
SCM
AFIMH
DA
Cambridge Trust's Q2 2018 Portfolio in Review
As of Q2 2018, Cambridge Trust held 254 positions worth $1.61B, up 2.7% from $1.57B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Cambridge Trust's Q2 2018 filing shows 8 new, 72 increased, 125 reduced and 12 closed positions. Its largest new stake was Roper Technologies: 2,564 shares worth $707K. The largest sale was iShares MSCI Europe Financials ETF, an estimated $21.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- Cambridge Trust's largest Q2 2018 buy was Roper Technologies: 2,564 shares worth $707K.
- Cambridge Trust added most to Verizon in Q2 2018, an estimated $10.3M increase.
- Cambridge Trust's biggest Q2 2018 reduction was iShares MSCI Europe Financials ETF, cutting an estimated $21.9M.
- Cambridge Trust fully exited Blue Buffalo Pet Products, Inc in Q2 2018, selling an estimated $1.34M.
- Cambridge Trust's ten largest holdings make up 26% of its $1.61B portfolio in Q2 2018.
- Cambridge Trust opened 8 new positions and closed 12 in Q2 2018.
- Cambridge Trust's portfolio value rose 2.7% quarter-over-quarter to $1.61B.
Based on Cambridge Trust's 13F filing for Q2 2018, filed 6 Aug 2018.